Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The study established an immunomodulating effect of preparations of human leukocytic interferon in spontaneous rosette-formation test (E--RFC) and leukocyte adherence inhibition reaction (LAI) which takes place both in healthy donors and patients with cervical carcinoma. In E--RFC test, administration of interferon preparations caused the E-rosette forming cell fraction to increase in donors. A similar but much lower effect was observed in the patient group. The effect of interferon produced by patients leukocytes was low. In LAI test, interferon treatment eliminated tumor antigen-induced inhibition in cases of cell-mediated immunity. However, it failed to materially affect the fraction of adhering cells in cases of negative reaction.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!